Sign Up Today and Learn More About Proniras Corp Stock
Invest in or calculate the value of your shares in Proniras Corp or other pre-IPO companies through EquityZen's platform.
Proniras Corp Stock (PRCR)
Proniras Corp focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.
About Proniras Corp Stock
Founded
2016
Headquarters
Seattle, WA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Proniras Corp Press Mentions
Stay in the know about the latest news on Proniras Corp
Proniras secures funding for Phase I opiate withdrawal study
clinicaltrialsarena • May 24, 2024
Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of ...
businesswire • Feb 11, 2024
IU Awarded $12M, Seeking Solutions to Opioid Withdrawal
ow • Sep 19, 2020
Proniras Corp Management
Leadership team at Proniras Corp
Board Member
Steven Gillis
CEO & Director
Thong Le
Join now and verify your accreditation status to gain access to:
- Proniras Corp current valuation
- Proniras Corp stock price
- Available deals in Proniras Corp and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Proniras Corp stock?
Accredited investors can buy pre-IPO stock in companies like Proniras Corp through EquityZen funds. These investments are made available by existing Proniras Corp shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Proniras Corp stock?
Shareholders can sell their Proniras Corp stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
